ERNA Archived Articles
Eterna Therapeutics (NASDAQ:ERNA): Pioneering Cell Therapies to Transform Cancer and Autoimmune Treatments
Published on March 11, 2025
Eterna Therapeutics (ERNA): Navigating the Challenges of the Biotech Landscape with Innovative Cell Therapy Solutions
Published on November 28, 2024
Eterna Therapeutics Inc. (NASDAQ:ERNA): Navigating the Challenges of Developing Transformative mRNA Therapies
Published on September 24, 2024